Compare SXTP & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXTP | GNLN |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Durable Goods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 2.1M |
| IPO Year | 2023 | 2019 |
| Metric | SXTP | GNLN |
|---|---|---|
| Price | $0.49 | $0.89 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.70 | N/A |
| AVG Volume (30 Days) | ★ 321.8K | 15.9K |
| Earning Date | 11-27-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.77 | 21.57 |
| EPS | ★ N/A | N/A |
| Revenue | $1,005,471.00 | ★ $13,275,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.49 | N/A |
| 52 Week Low | $0.34 | $0.81 |
| 52 Week High | $8.62 | $139.60 |
| Indicator | SXTP | GNLN |
|---|---|---|
| Relative Strength Index (RSI) | 29.77 | 18.94 |
| Support Level | N/A | N/A |
| Resistance Level | $1.01 | $3.28 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 6.02 | 0.00 |
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). It serves specialty retailers, smoke shops, head shops, convenience stores, and consumers. Geographically, it operates in United States, Canada, and Europe. It derives majority revenue from the United States. Its two operating segments are: Wholesale and Distribution, which includes legacy e-commerce and drop-ship operations; and Digital Assets, which includes digital asset treasury activities including acquisition, staking and validator participation related to BERA.